Zenlabs Ethica Limited

BSE:530697 Stock Report

Market Cap: ₹262.4m

Zenlabs Ethica Past Earnings Performance

Past criteria checks 2/6

Zenlabs Ethica has been growing earnings at an average annual rate of 20.6%, while the Healthcare industry saw earnings growing at 23.2% annually. Revenues have been declining at an average rate of 0.6% per year. Zenlabs Ethica's return on equity is 3.5%, and it has net margins of 0.6%.

Key information

20.6%

Earnings growth rate

21.1%

EPS growth rate

Healthcare Industry Growth29.4%
Revenue growth rate-0.6%
Return on equity3.5%
Net Margin0.6%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Zenlabs Ethica makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BSE:530697 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 245664580
30 Jun 245744450
31 Mar 245864580
31 Dec 23578-1520
30 Sep 23596-1520
30 Jun 236312420
31 Mar 236695530
31 Dec 226679520
30 Sep 2266710550
30 Jun 226759440
31 Mar 226918470
31 Dec 2168511400
30 Sep 2165911350
30 Jun 2162610310
31 Mar 215668410
31 Dec 205815370
30 Sep 20578-1390
30 Jun 20576-7390
31 Mar 20599-7430
31 Dec 19636-7620
30 Sep 196610560
30 Jun 196578430
31 Mar 1967313470
31 Dec 1867815560
30 Sep 1869217490
30 Jun 1876617480
31 Mar 1871812280
31 Dec 1773211650
30 Sep 1772210640
30 Jun 177268300
31 Mar 1781210660
31 Dec 1676212300
30 Sep 165876240
30 Jun 163647150
31 Mar 161582150
31 Dec 150-310
30 Sep 150-110
30 Jun 150-100
31 Mar 150-100
31 Dec 140-100
30 Sep 140-100
30 Jun 140-100
31 Mar 140-100
31 Dec 131000

Quality Earnings: 530697 has a large one-off gain of ₹2.1M impacting its last 12 months of financial results to 30th September, 2024.

Growing Profit Margin: 530697 became profitable in the past.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 530697 has become profitable over the past 5 years, growing earnings by 20.6% per year.

Accelerating Growth: 530697 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: 530697 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (33.2%).


Return on Equity

High ROE: 530697's Return on Equity (3.5%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies